| Literature DB >> 33921234 |
Mina Safarzadeh1, Ahmed Suhail1, Jagriti Sethi1, Anas Sattar2, David Jenkins1, Genhua Pan1.
Abstract
In this work, we developed a sandwich DNA-immunosensor for quantification of the methylaclass="Chemical">ted <class="Chemical">span class="Disease">tumour suppressor gene O-6-methylguanine-DNA methyltransferase (MGMT), which is a potential biomarker for brain tumours and breast cancer. The biosensor is based on aminated reduced graphene oxide electrode, which is achieved by ammonium hydroxide chemisorption and anti-5-methylcytosine (anti-5mC) as a methylation bioreceptor. The target single-strand (ss) MGMT oligonucleotide is first recognised by its hybridisation with complementary DNA to form double-stranded (ds) MGMT, which is then captured by anti-5mC on the electrode surface due to the presence of methylation. Raman spectroscopy, X-ray photoelectron spectroscopy (XPS) and Scanning electron microscopy (SEM) techniques were used to characterise the electrode surface. Cyclic voltammetry (CV) and differential pulse voltammetry (DPV) techniques were used for electrochemical measurements. Under optimised conditions, the proposed biosensor is able to quantify a linear range of concentrations of the MGMT gene from 50 fM to 100 pM with a limit of detection (LOD) of 12 fM. The sandwich design facilitates the simultaneous recognition and quantification of DNA methylation, and the amination significantly improves the sensitivity of the biosensor. This biosensor is label-, bisulfite- and PCR-free and has a simple design for cost-efficient production. It can also be tailor-made to detect other methylated genes, which makes it a promising detection platform for DNA methylation-related disease diagnosis and prognosis.Entities:
Keywords: MGMT gene; NH2 chemisorption; amination; quantification of DNA methylation; reduced graphene oxide (rGO)
Year: 2021 PMID: 33921234 PMCID: PMC8070590 DOI: 10.3390/nano11040985
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure A1SEM images of a bare rGO electrode (A), an aminated rGO electrode (B) and aminated electrodes after incubation in the antibody (C).
Figure A2Detection of 100 (purple) and 1000 (blue) pM of the target gene using either the antibody or antibody conjugated to protein G, using both CV (A) and DPV (B) techniques.
Figure A3Detection of 100 (purple) and 1000 (blue) pM of the target gene with various bovine serum albumin (BSA) optimisation times (5, 15 and 30 min), using both CV (A) and DPV (B) techniques.
Figure A4Detection of 100 (purple) and 1000 (blue) pM of the target gene of the target gene with various antibody incubation times (1, 2, 3, 4, 5, 6 and 8 h) using both CV (A) and DPV (B) techniques.
Figure A5Detection of 100 (purple) and 1000 (blue) pM of the target gene of the target gene with various antigen incubation times (30, 60, 90 and 120 min) using both CV (A) and DPV (B) techniques.
Optimised preparation steps and selected values.
| Experimental Variable | Range | Selected Value |
|---|---|---|
| Application of protein G | With-without protein G | With protein G |
| Anti-5mC incubation time, hours | 1–8 | 4 |
| BSA incubation time, hours | 5–30 | 15 |
| MGMT gene incubation time, hours | 30–120 | 60 |
Figure A7CV voltammograms of the aminated electrode under various scan rates from 0.025 V/s to 0.3 V/s (0.025, 0.05, 0.075, 0.1, 0.125, 0.15, 0.175, 0.2, 0.225, 0.275 and 0.3 V/s) (A). Anodic and Cathodic peaks as a function of the square root of the scan rate (B) and the scan rate (C).
Figure 1Raman spectra obtained from a bare reduced graphene oxide (rGO) electrode and rGO electrode incubated in ammonium hydroxide. Both the G (1578 cm) and D (1340 cm) bands decreased and broadened after rGO amination while the ratio increased from 0.6 to 0.7.
Figure 2XPS spectra of rGO and aminated rGO electrodes. Survey scan of a bare rGO electrode (a) and an aminated electrode (b). N1s high resolution spectra of bare rGO (c) and aminated rGO (d) electrodes and C1s high resolution spectra of bare rGO (e) and aminated rGO (f) electrodes.
Figure 3Schematic of the possible surface reactions that may occur on the rGO electrode after incubation in ammonium hydroxide. These reactions would lead to the presence of amine functional groups on the surface.
Figure 4Schematic display of the developed method for the quantification of O-6-methylguanine-DNA methyltransferase (MGMT) oligonucleotide (a). Electrodes were incubated in ammonium hydroxide and were kept in a vacuum for further use. Cyclic voltammetry (CV) (b) and differential pulse voltammetry (DPV) (c) characteristics of the sensor after each assembly steps in 10 mM K[Fe(CN)] containing 1 M KCl.
Figure A6Comparison of the responses obtained from various targets (methylated, non-methylated and blank) using the proposed biosensor. Normalized CV peak current for different samples measured on three different replicas (A). CV (B) and DPV (C) voltammograms of one replica for each sample.
Figure 5Calibration curves constructed with normalised peak currents of DPV responses as a function of the logarithm of the concentration of target ssDNA (red) and dsDNA (black). For both targets, the current increases with increases in concentration. Error bars are the standard deviation of three replicates.
An overview of the electrochemical affinity biosensor to date for the detection of DNA methylation.
| Electrode | Bioreceptor | Dynamic Range/LOD | Technique | Reference |
|---|---|---|---|---|
| Gold modified with gold nanoparticles | DNA probe, methyl binding protein, gold nanoparticle, antibody | 0.5–500 pM/0.17 pM | DPV | [ |
| SPCE modified with polythiophene | Anti-5mC and Fe | 0.01–1000 pM/0.002 pM | DPV | [ |
| SPCE | Biotinylated DNA probe immobilised on magnetic beads and anti-5mC | 87–2500 pM/26 pM | DPV | [ |
| SPCE | Anti-5mC immobilised on magnetic beads and biotinylated DNA probe | 3.9–500 pM/1.2 pM | DPV | [ |
| SPCE modified with rGO and polyvinyl alcohol | Anti-5mC immobilised and DNA probe conjugated with Fe | 7×10 | DPV/EIS | [ |
| rGO modified with ammuniom hydroxide | Anti5-mC and complementary DNA | 0.5–100 pM/0.012 pM | DPV/EIS | This work |